Analyst Ratings for BeOne Medicines (ONC)
ONC Rating Summary
ONC Price Target Summary
- Highest: $459.00 (RBC Capital)
- Lowest: $340.00 (Wolfe Research)
- Average: $419.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$419.83 (+13.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$419.83 (+13.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Jefferies | Faisal Khurshid | Upgrade | Buy (Hold) |
380.00 (333.00) |
302.83 (369.06) |
21.87% | Details |
| 5/20/2026 | JPMorgan » Updated 10/1/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
445.00 (425.00) |
293.09 (369.06) |
25.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
